Total Payments
$47,745
2024 Payments
$797.80
Companies
36
Transactions
283
Medicare Patients
1,020
Medicare Billing
$218,505
Payment Breakdown by Category
Other$38,500 (80.6%)
Food & Beverage$8,497 (17.8%)
Travel$747.76 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,500 | 14 | 59.7% |
| Honoraria | $10,000 | 5 | 20.9% |
| Food and Beverage | $8,497 | 261 | 17.8% |
| Travel and Lodging | $747.76 | 3 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, LLC | $40,695 | 40 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $1,099 | 44 | $0 (2021) |
| GlaxoSmithKline, LLC. | $1,052 | 36 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $556.35 | 39 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $506.38 | 37 | $0 (2019) |
| Melinta Therapeutics, Inc. | $415.11 | 9 | $0 (2018) |
| PFIZER INC. | $276.19 | 16 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $275.30 | 4 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $236.70 | 2 | $0 (2024) |
| GENZYME CORPORATION | $235.85 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $797.80 | 13 | GlaxoSmithKline, LLC. ($160.85) |
| 2023 | $466.06 | 11 | GENZYME CORPORATION ($117.93) |
| 2022 | $733.43 | 27 | GlaxoSmithKline, LLC. ($357.86) |
| 2021 | $541.83 | 19 | E.R. Squibb & Sons, L.L.C. ($237.18) |
| 2020 | $2,421 | 13 | PORTOLA PHARMACEUTICALS, LLC ($2,128) |
| 2019 | $9,445 | 41 | PORTOLA PHARMACEUTICALS, INC. ($8,265) |
| 2018 | $31,445 | 73 | PORTOLA PHARMACEUTICALS, INC. ($30,302) |
| 2017 | $1,894 | 86 | Otsuka America Pharmaceutical, Inc. ($375.59) |
All Payment Transactions
283 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: Pulmonology | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.26 | General |
| Category: Narcoplepsy | ||||||
| 09/24/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: Neurology | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $101.33 | General |
| Category: Respiratory | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: RESPIRATORY | ||||||
| 07/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $117.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/26/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $106.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $119.10 | General |
| 12/11/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $22.42 | General |
| Category: Respiratory | ||||||
| 11/30/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $47.95 | General |
| Category: SLEEP MEDICINE | ||||||
| 11/02/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: Respiratory | ||||||
| 09/11/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.77 | General |
| Category: SLEEP MEDICINE | ||||||
| 06/06/2023 | Olympus America Inc. | Spiration Valve System (Device) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: Endotherapy | ||||||
| 06/05/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $18.68 | General |
| Category: Respiratory | ||||||
| 03/30/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $117.93 | General |
| Category: Immunology | ||||||
| 03/30/2023 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $19.39 | General |
| Category: Respiratory | ||||||
| 03/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: RESPIRATORY | ||||||
| 03/07/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $55.93 | General |
| Category: SURGERY | ||||||
| 01/26/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Urology | ||||||
| 12/13/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $30.90 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 254 | 449 | $135,734 | $50,881 |
| 2022 | 5 | 270 | 446 | $170,008 | $54,382 |
| 2021 | 4 | 219 | 364 | $151,860 | $48,742 |
| 2020 | 5 | 277 | 519 | $167,311 | $64,500 |
Total Patients
1,020
Total Services
1,778
Medicare Billing
$218,505
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 103 | 250 | $63,500 | $24,729 | 38.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 51 | 71 | $34,372 | $12,442 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 36 | 44 | $14,477 | $5,119 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 36 | 56 | $12,438 | $4,585 | 36.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $6,866 | $2,474 | 36.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,081 | $1,532 | 37.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 105 | 152 | $93,024 | $27,485 | 29.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 97 | 201 | $44,196 | $17,182 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 30 | 42 | $16,800 | $4,726 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 27 | 40 | $11,346 | $3,140 | 27.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 11 | $4,642 | $1,848 | 39.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 94 | 161 | $98,636 | $30,261 | 30.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 65 | 124 | $27,387 | $11,009 | 40.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 34 | 51 | $14,637 | $3,899 | 26.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 26 | 28 | $11,200 | $3,573 | 31.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 123 | 192 | $92,859 | $36,892 | 39.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 80 | 206 | $46,556 | $18,540 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 39 | 63 | $15,336 | $4,081 | 26.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 22 | 45 | $6,840 | $2,732 | 39.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $5,720 | $2,256 | 39.4% |
About Dr. Heather Davis, MD
Dr. Heather Davis, MD is a Critical Care Medicine healthcare provider based in Claremont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154390391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heather Davis, MD has received a total of $47,745 in payments from pharmaceutical and medical device companies, with $797.80 received in 2024. These payments were reported across 283 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,500).
As a Medicare-enrolled provider, Davis has provided services to 1,020 Medicare beneficiaries, totaling 1,778 services with total Medicare billing of $218,505. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Sleep Medicine, Pulmonary Disease
- Location Claremont, CA
- Active Since 03/17/2006
- Last Updated 08/23/2019
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1154390391
Products in Payments
- BEVYXXA (Drug) $30,302
- ANDEXXA (Biological) $10,393
- ELIQUIS (Drug) $817.17
- INVOKANA (Drug) $595.44
- XARELTO (Drug) $503.25
- SAMSCA (Drug) $483.49
- TRELEGY ELLIPTA (Drug) $452.82
- Baxdela (Drug) $403.95
- DUPIXENT (Biological) $353.77
- SOLIQUA (Drug) $185.28
- ANORO (Drug) $156.82
- Adempas (Drug) $135.48
- UPTRAVI (Drug) $132.02
- AFREZZA (Drug) $125.00
- AREXVY (Drug) $125.00
- Monarch Platform (Device) $125.00
- SINGLE USE SUCTION VALVE (Sterile) (Device) $125.00
- ZEPHYR DELIVERY CATHETER (Device) $125.00
- JARDIANCE (Drug) $117.60
- INCRUSE (Drug) $116.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.